The result of the recessive model comparison showed no evidence that HIF1A P582S polymorphism conferred to an increased urinary cancers risk in Caucasian population (TT vs CT+CC OR = 1.57, 95% CI = 0.22–11.14, Pheterogeneity = 0.04, P = 0.65) (Table 3). This evidence concerns the gene HIF1A and cancer.